EVERSANA is an independent provider of global commercial services to the life sciences industry. Operating across more than 20 locations worldwide with a team of over 6,000 professionals, the company combines consulting, technology, patient services, market access, and marketing agency capabilities into a single integrated platform designed to support drug commercialization across the full product lifecycle - from launch readiness through to established brand management.
The company's service portfolio spans a broad range of functions relevant to pharmaceutical and biotechnology clients. These include advisory consulting, field deployment, patient support programs, specialty pharmacy, and market access services. Its agency offering, EVERSANA INTOUCH, operates as an AI-powered platform that brings together data analytics and marketing capabilities. Across all its services, EVERSANA positions technology and data - including artificial intelligence - as central to how it delivers commercialization solutions.
EVERSANA serves clients across the life sciences sector globally, working with pharmaceutical, biotechnology, and healthcare organizations. Its integrated structure means that professionals across the business - whether in consulting, technology, patient services, or agency work - operate within a common commercialization framework rather than as siloed business units.